Japan in talks to secure coronavirus vaccine from AstraZeneca

Daiichi Sankyo to distribute doses if UK development is successful

20200626 AstraZeneca for blog

AstraZeneca aims to supply Japan with a vaccine in cooperation with its group companies, Daiichi Sankyo and Meiji Holdings. © Reuters

FRANCESCA REGALADO, Nikkei staff writer

TOKYO -- Japanese pharmaceutical company Daiichi Sankyo is in discussions to secure Japan supplies of a potential coronavirus vaccine being developed by British pharmaceutical giant AstraZeneca and Oxford University.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.